BioSpace News Archive

Growing elderly population and rising prevalence of chronic diseases along with focus on early detection of diseases and increasing investments in research and development activities are fueling market growth.

Tevogen Bio announces Dr. Neal Flomenberg, M.D., Professor and Chairman of the Department of Medical Oncology at Thomas Jefferson University, and Chairman of Tevogen’s Scientific Advisory Board, presented data detailing immunologic escape underscoring criticality of Tevogen’s proprietary Cytotoxic T Lymphocyte (CTL) Target Tuning Technology.

Increasing industrial applications of humic acid and growing scale of organic farming worldwide due to rising environmental concerns are among the key factors expected to drive market revenue growth.

Rapid industrialization worldwide and growing applications of hydrochloric acid in oil & gas production, water treatment, food processing, and pharmaceutical manufacturing are among the key factors expected to drive market revenue growth over the forecast period.

Surge in geriatric population, implementation of advanced treatment procedures, rising prevalence of osteoarthritis globally are some key factors expected to drive market growth.

According to Emergen Research, the global healthcare distribution market size was USD 808.13 billion in 2020 and is expected to reach USD 1,384.59 billion in 2028 and register a revenue CAGR of 7.0% during the forecast period, 2021-2028.

ResoluteAI, the research platform for science, today released their next generation API to facilitate the integration of scientific research data into third party platforms and customer-developed solutions.

Arthrosi Therapeutics, Inc., a clinical-stage biotech company announced today patient enrollment in a global phase 2b study of AR882, its novel drug candidate.

Teledyne e2v HiRel announces the availability of a rad-tolerant X-Band Low Noise Amplifier, model TDLNA001013 that is ideal for use in demanding high reliability, space and defense applications.

Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the acquisition of Wisconsin-based Matrex Mold and Tool, Inc., a custom mold manufacturer for plastic injection molding.